Loading...
•
Sep 28, 2024
Thermo Fisher Q3 2024 Earnings Report
Thermo Fisher's financial performance remained stable in Q3 2024, marked by strategic advancements and partnerships.
Key Takeaways
Thermo Fisher Scientific reported third-quarter revenue of $10.60 billion and GAAP diluted EPS of $4.25. The company is raising its full-year adjusted EPS guidance to a new range of $21.35 to $22.07.
Third quarter revenue was $10.60 billion.
Third quarter GAAP diluted earnings per share (EPS) was $4.25.
Third quarter adjusted EPS was $5.28.
The company launched innovative new products, including the Thermo Scientific Iliad scanning transmission electron microscope and the Applied Biosystems MagMAX Sequential DNA/RNA kit.
Revenue by Segment
Forward Guidance
Thermo Fisher is raising its full-year adjusted EPS guidance to a new range of $21.35 to $22.07 versus its previous guidance of $21.29 to $22.07. Revenue guidance continues to be in the range of $42.4 to $43.3 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...